Nipro launches its innovative Direct-to-Fill glass vials

Nipro PharmaPackaging, a global leader in glass tubing, glass primary packaging, and medical devices, has launched its D2F™ (Direct-to-Fill) glass vials.

Featuring Stevanato Group’s advanced EZ-fill^® technology, Nipro offers a high-quality ready-to-use (RTU) solution designed to meet the rigorous standards and increasing requirements of the pharmaceutical industry.

Key features of D2F™ glass vials include:

• Direct-to-Fill Technology: D2F™ glass vials are washed, depyrogenated, packaged in nest & tub formats, and sterilized providing a seamless ready-to-use (RTU) solution. Pharmaceutical companies can integrate these vials directly into their aseptic fill-finish processes.
• Optimized for fill-finish lines: Developed in collaboration with leading machine suppliers, D2F™ vials are compatible with a wide range of fill-finish lines, ensuring easy and quick integration, thus speeding up operations.
• Increased stability and cost efficiency: D2F™ vials’ nest and tub design prevents glass-to-glass contact, reducing risks of breakage, cosmetic defects, and particle generation during transportation and handling. This results in improved mechanical durability, lower downtime, and fewer rejections during final inspections, ultimately contributing to more stable and cost-efficient fill-finish operations.

Whether for vaccines, biologics, or other sensitive medications, Nipro offers precise solutions tailored to the unique needs of both standard and complex drug products.

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>